Literature DB >> 30298332

Lifespan Development: Symptoms Experienced by Individuals with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas from Childhood into Adulthood.

Sally E Jensen1, Zabin S Patel1, Robert Listernick2,3,4, Joel Charrow2,3,5, Jin-Shei Lai6,7,8,9.   

Abstract

This secondary data analysis qualitatively identified salient concerns reported by individuals with Neurofibromatosis Type 1 (NF1)-associated plexiform neurofibromas (pNFs) at different stages of development. Past literature has focused on overall symptomatology, but has not examined nuances in how these symptoms are experienced across developmental phases. Therefore, we aimed to identify commonalities and differences in symptom experiences across age groups to better assist individuals to adjust to symptoms across the lifespan. Thirty-one children, adolescents, and adults (age ≥ 5 years old) and 15 parents participated in semi-structured interviews. Analyses focused on the following symptom categories: pain, social functioning, physical function impact, and stigma. Aspects of pain endorsed by all age groups included localized brief pain on contact with pNF and abnormal sensations; however, only adolescents and adults reported chronic pain and change in pain over time. Social functioning themes of limited activity participation, role limitations, and relationship impact were endorsed by all age groups, but differences emerged across age groups in the types of activity and role limitations, the type of relationship impact, and family planning concerns. All age groups described difficulty with mobility, but only parents reported problems with coordination and physical developmental milestones. While all age groups reported external stigma, internalized stigma was predominately endorsed by adults. While individuals in all age groups described pNF concerns related to pain, social function, physical function, and stigma, specific aspects of these symptoms differed across the developmental continuum. These findings can help assist individuals with pNF better transition to the next developmental phases.

Entities:  

Keywords:  Lifespan; Neurofibromatosis Type 1; Plexiform neurofibroma; Qualitative; Symptoms

Mesh:

Year:  2019        PMID: 30298332     DOI: 10.1007/s10880-018-9584-5

Source DB:  PubMed          Journal:  J Clin Psychol Med Settings        ISSN: 1068-9583


  22 in total

Review 1.  Neurofibromatosis 1: clinical manifestations and diagnostic criteria.

Authors:  J M Friedman
Journal:  J Child Neurol       Date:  2002-08       Impact factor: 1.987

2.  NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight.

Authors:  E Dombi; J Solomon; A J Gillespie; E Fox; F M Balis; N Patronas; B R Korf; D Babovic-Vuksanovic; R J Packer; J Belasco; S Goldman; R Jakacki; M Kieran; S M Steinberg; B C Widemann
Journal:  Neurology       Date:  2007-01-10       Impact factor: 9.910

3.  Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1.

Authors:  Anna Graf; Markus A Landolt; Andrea Capone Mori; Eugen Boltshauser
Journal:  J Pediatr       Date:  2006-09       Impact factor: 4.406

Review 4.  On the road to nowhere? Young disabled people and transition.

Authors:  B Beresford
Journal:  Child Care Health Dev       Date:  2004-11       Impact factor: 2.508

Review 5.  Plexiform neurofibromas.

Authors:  B R Korf
Journal:  Am J Med Genet       Date:  1999-03-26

6.  Transitions in the lives of young people with complex healthcare needs.

Authors:  S Kirk
Journal:  Child Care Health Dev       Date:  2008-09       Impact factor: 2.508

7.  Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.

Authors:  T Tucker; J M Friedman; R E Friedrich; R Wenzel; C Fünsterer; V-F Mautner
Journal:  J Med Genet       Date:  2008-10-17       Impact factor: 6.318

8.  Young people with chronic illness: the approach to transition.

Authors:  A Kennedy; F Sloman; J A Douglass; S M Sawyer
Journal:  Intern Med J       Date:  2007-08       Impact factor: 2.048

9.  The self-concept of children and adolescents with neurofibromatosis type 1.

Authors:  B Barton; K North
Journal:  Child Care Health Dev       Date:  2007-07       Impact factor: 2.508

10.  Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1.

Authors:  Victor-F Mautner; Florence A Asuagbor; Eva Dombi; Carsten Fünsterer; Lan Kluwe; Ralf Wenzel; Brigitte C Widemann; Jan M Friedman
Journal:  Neuro Oncol       Date:  2008-06-17       Impact factor: 12.300

View more
  2 in total

1.  Longitudinal Investigation of Early Motor Development in Neurofibromatosis Type 1.

Authors:  Sara K Pardej; Danielle M Glad; Christina L Casnar; Kelly M Janke; Bonita P Klein-Tasman
Journal:  J Pediatr Psychol       Date:  2022-02-14

2.  The Number of Surgical Interventions and Specialists Involved in the Management of Patients with Neurofibromatosis Type I: A 25-Year Analysis.

Authors:  Chih-Kai Hsu; Rafael Denadai; Chun-Shin Chang; Chuan-Fong Yao; Ying-An Chen; Pang-Yun Chou; Lun-Jou Lo; Yu-Ray Chen
Journal:  J Pers Med       Date:  2022-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.